Niflumic Acid

Niflumic Acid

SCHEMBL10435526

O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1.[NaH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.97
DHODH Q02127 5/20 0.97
MEN1 O00255 4/20 0.97
KMT2A Q03164 4/20 0.97
PKM P14618 2/20 0.97
ALDH1A1 P00352 2/20 0.97
GMNN O75496 1/20 0.97
TTR P02766 1/20 0.97
CYP1A2 P05177 1/20 0.97
CYP3A4 P08684 1/20 0.97
CYP2C9 P11712 1/20 0.97
NFKB1 P19838 1/20 0.97
UGT1A1 P22309 1/20 0.97
PTGS1 P23219 1/20 0.97
PTGS2 P35354 1/20 0.97
PMP22 Q01453 1/20 0.97
TEAD4 Q15561 1/20 0.97
HIF1A Q16665 1/20 0.97
GPR35 Q9HC97 1/20 0.97
TDP1 Q9NUW8 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niflumic Acid SCHEMBL29373503 0.99 DHODH (1.00) LMNADHODHMEN1KMT2APKM
Niflumic Acid SCHEMBL24706 0.99 DHODH (1.00) LMNADHODHMEN1KMT2APKM
Niflumic Acid SCHEMBL29364001 0.99 DHODH (1.00) LMNADHODHMEN1KMT2APKM
Niflumic Acid SCHEMBL4886924 0.99 DHODH (1.00) LMNADHODHMEN1KMT2APKM
Niflumic Acid SCHEMBL8925125 0.97 DHODH (0.97) LMNADHODHMEN1KMT2APKM
Niflumic Acid SCHEMBL5251418 0.91 LMNA (0.84) LMNADHODHMEN1KMT2APKM
Niflumic Acid SCHEMBL5305825 0.89 LMNA (0.81) LMNADHODHMEN1KMT2APKM
SCHEMBL12608890 0.87 LMNA (0.79) LMNADHODHMEN1KMT2APKM
SCHEMBL4204237 0.87 LMNA (0.79) LMNADHODHMEN1KMT2APKM
SCHEMBL22492824 0.86 LMNA (0.78) LMNADHODHMEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115813902-A Use of substituted hexitols for the treatment of malignant tumors 德玛公司 2023-03-21 CN disclosed
CN-115778934-A Use of substituted hexitols for the treatment of malignant tumors 德玛公司 2023-03-14 CN disclosed
CN-110711188-A Use of substituted hexitols for the treatment of malignant tumors 德玛公司 2020-01-21 CN disclosed
CN-1763012-A Sodium niflumic acid production process GU YUMEI (CN) 2006-04-26 CN disclosed
EP-0349902-A2 Processes for the preparation of morniflumate and analogous compounds CHIESI FARMACEUTICI S.p.A. (IT) 1990-01-10 EP disclosed